Cite
HARVARD Citation
Radford-Smith, D. et al. (n.d.). P494 A serum metabolite panel predicts Crohn's disease relapse in patients discontinuing infliximab and continuing antimetabolite therapy: sub-analysis of the SPARE Trial. Journal of Crohn's and colitis. pp. i458-i460. [Online].